Posted by Michael Wonder on 21 May 2022
PTC Therapeutics receives positive CHMP opinion for Upstaza for the treatment of AADC deficiency
20 May 2022 - First ever gene therapy directly administered into the brain.
PTC Therapeutics today announced that Upstaza (eladocagene exuparvovec) received a positive opinion from the CHMP of the EMA.
